Literature DB >> 26543630

The multidrug-resistant tuberculosis threat: old problems and new solutions.

Giovanni Sotgiu1, Lia D'Ambrosio1, Rosella Centis1, Ida Mura1, Paolo Castiglia1, Antonio Spanevello1, Giovanni Battista Migliori1.   

Abstract

Entities:  

Year:  2015        PMID: 26543630      PMCID: PMC4598488          DOI: 10.3978/j.issn.2072-1439.2015.09.21

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  34 in total

1.  Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?

Authors:  G B Migliori; R Centis; L D'Ambrosio; A Spanevello; E Borroni; D M Cirillo; G Sotgiu
Journal:  Clin Infect Dis       Date:  2012-05       Impact factor: 9.079

2.  Ertapenem in the treatment of multidrug-resistant tuberculosis: first clinical experience.

Authors:  Simon Tiberi; Lia D'Ambrosio; Saverio De Lorenzo; Pietro Viggiani; Rosella Centis; Giovanni Sotgiu; Jan Wilem C Alffenaar; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2015-11-19       Impact factor: 16.671

3.  Efficacy and safety of meropenem-clavulanate added to linezolid-containing regimens in the treatment of MDR-/XDR-TB.

Authors:  Saverio De Lorenzo; Jan Wilem Alffenaar; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Mathieu S Bolhuis; Richard van Altena; Piero Viggiani; Andrea Piana; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2012-09-20       Impact factor: 16.671

4.  Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

Authors:  A H Diacon; P R Donald; A Pym; M Grobusch; R F Patientia; R Mahanyele; N Bantubani; R Narasimooloo; T De Marez; R van Heeswijk; N Lounis; P Meyvisch; K Andries; D F McNeeley
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

Review 5.  Surgical interventions for drug-resistant tuberculosis: a systematic review and meta-analysis.

Authors:  M T Marrone; V Venkataramanan; M Goodman; A C Hill; J A Jereb; S R Mase
Journal:  Int J Tuberc Lung Dis       Date:  2013-01       Impact factor: 2.373

Review 6.  Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.

Authors:  Elias B Chahine; Lamis R Karaoui; Hanine Mansour
Journal:  Ann Pharmacother       Date:  2013-11-01       Impact factor: 3.154

7.  TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?

Authors:  G B Migliori; G Sotgiu; L D'Ambrosio; R Centis; C Lange; G Bothamley; D M Cirillo; S De Lorenzo; G Guenther; K Kliiman; R Muetterlein; V Spinu; M Villar; J P Zellweger; A Sandgren; E Huitric; D Manissero
Journal:  Eur Respir J       Date:  2012-02-09       Impact factor: 16.671

8.  A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis.

Authors:  G B Migliori; B Eker; M D Richardson; G Sotgiu; J-P Zellweger; A Skrahina; J Ortmann; E Girardi; H Hoffmann; G Besozzi; N Bevilacqua; D Kirsten; R Centis; C Lange
Journal:  Eur Respir J       Date:  2009-03-12       Impact factor: 16.671

9.  Delamanid improves outcomes and reduces mortality in multidrug-resistant tuberculosis.

Authors:  Vija Skripconoka; Manfred Danilovits; Lea Pehme; Tarmo Tomson; Girts Skenders; Tiina Kummik; Andra Cirule; Vaira Leimane; Anu Kurve; Klavdia Levina; Lawrence J Geiter; Davide Manissero; Charles D Wells
Journal:  Eur Respir J       Date:  2012-09-27       Impact factor: 16.671

10.  Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

Authors:  Alena Skrahina; Henadz Hurevich; Aksana Zalutskaya; Evgeni Sahalchyk; Andrei Astrauko; Wayne van Gemert; Sven Hoffner; Valiantsin Rusovich; Matteo Zignol
Journal:  Eur Respir J       Date:  2011-10-17       Impact factor: 16.671

View more
  4 in total

1.  The link between tuberculosis and body mass index.

Authors:  Aaron R Casha; Marco Scarci
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

Review 2.  Strategies in anti-Mycobacterium tuberculosis drug discovery based on phenotypic screening.

Authors:  Edyta M Grzelak; Mary P Choules; Wei Gao; Geping Cai; Baojie Wan; Yuehong Wang; James B McAlpine; Jinhua Cheng; Yingyu Jin; Hanki Lee; Joo-Won Suh; Guido F Pauli; Scott G Franzblau; Birgit U Jaki; Sanghyun Cho
Journal:  J Antibiot (Tokyo)       Date:  2019-07-11       Impact factor: 2.649

3.  Uncovering the Resistance Mechanism of Mycobacterium tuberculosis to Rifampicin Due to RNA Polymerase H451D/Y/R Mutations From Computational Perspective.

Authors:  Qianqian Zhang; Xiaoli An; Hongli Liu; Shuo Wang; Tong Xiao; Huanxiang Liu
Journal:  Front Chem       Date:  2019-12-03       Impact factor: 5.221

4.  Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice.

Authors:  Hongbo Shen; Feifei Wang; Gucheng Zeng; Ling Shen; Han Cheng; Dan Huang; Richard Wang; Lijun Rong; Zheng W Chen
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.